SUMMARY. |8i-and |8 2 -Adrenergic receptors co-exist in the adult rat ventricle. We have employed radioligand binding and cell purification techniques to determine the cellular origin of these receptors. The /3-adrenergic antagonist ligand (±) I]iodocyanopindolol binding by betaxolol, practolol, and zinterol in nonmyocyte membranes demonstrates biphasic curves that comprise binding to both ft-and ^-receptors. These data demonstrate that purified adult ventricular myocytes possess only f), -receptors, and that the 182-receptors found in rat ventricle are located on nonmyocyte cell types (Circ Res 56:126-132, 1985) EVIDENCE for the co-existence of ft-and /^-receptors for catecholamines in the mammalian myocardium comes from both physiological and radioligand binding studies. Carlsson et al. (1972 Carlsson et al. ( , 1977 present evidence that the inotropic and chronotropic responses of the cat heart to catecholamines are differentially antagonized by subtype-specific ^-antagonists. Studies in guinea pig heart lead to the same conclusion (Dreyer and Offermeir, 1975) . Radioligand binding studies, employing heterogeneous membranes prepared from homogenized hearts, reveal the presence of both ftreceptor subtypes in rat (Minneman et al., 1979a (Minneman et al., , 1979b , kitten (Kaumann et al., 1983) and human heart (Stiles et al., 1983; Waelbroeck et al., 1983) . Although these data demonstrate the presence of both ft-and /3 2 -receptors in mammalian heart, they do not describe the distribution of ftadrenergic receptor subtypes among different cell types within the ventricle.
I]iodocyanopindolol binds to 2 X 10 5 receptors per purified adult rat cardiomyocyte, with a dissociation constant of 70 DM. The subtypeselective antagonists betaxolol (pi), practolol (/3i), and zinterol (&) compete for [' 25 I]iodocyanopindolol-binding sites on intact myocytes in monophasic manners with dissociation constants of 46, 845, and 923 nM, respectively. [ I]iodocyanopindolol binding to membranes prepared from nonmyocyte elements of rat ventricle occurs with a dissociation constant of 43 pM and a capacity of 88 fmol/mg membrane protein. Computer analysis of competition of [ 125 I]iodocyanopindolol binding by betaxolol, practolol, and zinterol in nonmyocyte membranes demonstrates biphasic curves that comprise binding to both ft-and ^-receptors. These data demonstrate that purified adult ventricular myocytes possess only f), -receptors, and that the 182-receptors found in rat ventricle are located on nonmyocyte cell types (Circ Res 56:126-132, 1985) EVIDENCE for the co-existence of ft-and /^-receptors for catecholamines in the mammalian myocardium comes from both physiological and radioligand binding studies. Carlsson et al. (1972 Carlsson et al. ( , 1977 present evidence that the inotropic and chronotropic responses of the cat heart to catecholamines are differentially antagonized by subtype-specific ^-antagonists. Studies in guinea pig heart lead to the same conclusion (Dreyer and Offermeir, 1975) . Radioligand binding studies, employing heterogeneous membranes prepared from homogenized hearts, reveal the presence of both ftreceptor subtypes in rat (Minneman et al., 1979a (Minneman et al., , 1979b , kitten (Kaumann et al., 1983) and human heart (Stiles et al., 1983; Waelbroeck et al., 1983) . Although these data demonstrate the presence of both ft-and /3 2 -receptors in mammalian heart, they do not describe the distribution of ftadrenergic receptor subtypes among different cell types within the ventricle.
In the course of our own work on the hormonal regulation of cardiac function and metabolism, we have wondered whether specific hormone receptors (and, hence, distinct responses) can be assigned to particular cell types within the heart. In particular, we have considered whether ft-and ft-receptors co-exist on ventricular myocytes. To approach these questions experimentally, we have combined the techniques of radioligand binding and cell purification. Specifically, we have measured the distribution of ftreceptor subtypes on purified cardiomyocytes from adult rat ventricle and on the nonmyocyte elements of ventricle by employing the subtype nonselective /J-adrenergic antagonist (±) 
Methods

Preparation of Ventricular Cardiomyocytes
Male Sprague-Dawley rats were given heparin (1500 U/kg, ip) and sodium pentobarbital (12 mg, ip), and were killed 10 minutes later. Hearts were rapidly removed and immediately perfused with Ca ++ -free basal medium Eagle (BME, 18°C) via the aorta to stop spontaneous beating and to remove blood cells. Hearts were trimmed of extraneous tissue including pericardium, and mounted via the aorta in a recirculating perfusion apparatus. Ventricular myocytes were prepared by collagenase perfusion in the absence of Ca ++ by a method we have previously described in detail (Buxton and Brunton, 1983) . For experiments, purified myocytes were resuspended in BME containing CaCl 2 (1 mM) and BSA (0.01% wt/vol). Viability of myocytes was determined by their capacity to exclude trypan blue (1 volume of cells plus 9 volumes of 0.3% trypan blue). Myocytes were routinely 80-90% rodshaped cells excluding trypan blue. Myocytes were used in experiments 15-20 minutes after their purification.
nitrogen. Membranes were prepared from frozen tissue as described below.
Preparation of Myocyte, Nonmyocyte, and Liver Membranes
Tissue determined to be 'nonmyocyte" in origin included tissue pieces remaining after filtration of enzymereleased myocytes, as well as cells contained in the first supernatant from myocyte purification. Microscopic examination of this material confirmed the presence of numerous small nonmuscle cells, damaged myocytes, and collagen fibers. Thus, while not devoid of myocyte membrane, this material was enriched for nonmyocyte, cell types present in rat ventricle. Both purified myocytes and nonmyocytes were collected by centrifugation (1000 g X 2 minutes) and quick-frozen in liquid nitrogen. Whole rat ventricle and liver were freeze-clamped at the temperature of liquid nitrogen. For the preparation of membranes, frozen tissues and frozen cell pellets were powdered at -70°C and then homogenized (50 HIM Tris, 10 ITIM MgCl 2 , 1 mM EDTA, pH 7.5, 4°C) in glass-glass homogenizing tubes (Kontes) and filtered through Nitex cloth (149 jtm). Membranes were collected by centrifugation (3000 g x 5 minutes) and suspended in homogenizing buffer at 1-2 mg protein/ml. Protein was determined by the method of Bradford (1976) .
Radioligand Binding Assay
Radioiodinated cyanopindolol was the generous gift of Dr. Paul Insel, and was prepared as described previously (Engle et al., 1981) . Binding assays were performed in triplicate by incubating 2-3 X 10 3 myocytes, or 30-50 tig of membrane suspension with 0.1 ml of [ 125 I]ICYP (2200 Ci/mmol) and 0.1 ml of various /S-adrenergic antagonists or diluent in a final volume of 1.0 ml in polypropylene test tubes (16 X 105 mm Sarstedt, washed). Assays were initiated by the addition of myocytes or membranes diluted in BME immediately prior to addition to the assay. All tubes containing myocytes were gassed with O 2 /CO 2 (95%/5%) and capped. Equilibrium binding was carried out for 60-90 minutes at 34°C in a rotary water bath at 120 rpm. Assays were terminated with the addition of 10 ml of cold (4°C) hypotonic buffer (10 mM Tris, 1 mM EDJA, pH 7.5). Bound and free [ I25 I]ICYP were separated by rapid filtration over glass fiber filters (Whatman GF/ C). Filters were washed with an additional 10 ml of hypotonic buffer at 4°C. Radioactivity retained on filters was determined using a gamma counter at 86% efficiency. Replicate variation was less than 5% in all experiments. Nonspecific binding for both membranes and intact myocytes was determined by [ 
Data Analysis
The equilibrium dissociation constant (K D ) and maximal number of binding sites (B mox ) for [ 125 I]ICYP, a nonselective /3-adrenergic antagonist, on ventricular myocytes and ventricular nonmyocyte and liver membranes were determined from Scatchard analysis (Scatchard, 1949) of saturation binding isotherms. Competition curves employing j3-subtype-specific antagonists were analyzed by means of a computer program that performs iterative, nonlinear regression (Munson and Rodbard, 1980) . This program fits the binding data to equations describing the laws of mass action for one or two classes of binding sites and determines whether the two-site model is statistically better than the one-site fit of the data.
The affinity (KD) of the nonselective antagonist radioligand [ 125 I]ICYP was determined separately in each competition experiment with subtype-selective antagonists and either intact myocytes or membranes, and was entered in the computer analysis as a constant. Computer-generated fits of competition data provide estimates of the affinity constant (Ki) of subtype-specific antagonists and of the concentration of each receptor subtype. Further, computer analysis determined nonspecific binding from data obtained at high competitor concentrations which was indistinguishable from simultaneous measurements of binding in the presence of 1.0 fiM /-propranolol. The likelihood that more than one receptor subtype was present was decided by comparison of the residual variances obtained, assuming either one or two classes of binding sites (Munson and Rodbard, 1980) . The limitation of this computer method to detect small numbers of /8 2 -receptors on the ventricular myocyte derives from both precise measurements of binding at a given antagonist concentration (replicate variation <5%) and a large difference in the affinities (Ki) of subtype-selective agents for ft-vs. /3 2 -receptors (Delean et al., 1981 , and data of Table 1 ).
Results
Distribution of /3-Receptors in Myocardial Membranes
As a starting point to verify our techniques, we determined the distribution of ft-and ft-receptors in a membrane fraction of an homogenate of rat heart ventricle. (Fig. 1) . This relatively high proportion of ft-receptors suggested to us that we might reasonably expect to detect the appearance of even a moderate fraction of either receptor subtype in more purified fractions of cardiac tissue.
Characteristics and Distribution of /3-Receptors in Purified Myocytes
Binding of [ Table 1 .
To determine the relative proportion of ft-and ft-receptor subtypes on intact ventricular cardiomyocytes, we employed the ft -selective antagonists betaxolol and practolol and the ft-selective agent zinterol to compete for [ (Fig. 3) . The Ki value for both betaxolol (46 nM) and practolol (800 nM) is consistent with competition of these drugs for binding to a ftreceptor, whereas the Ki value calculated for zinterol binding (1.2 J*M) to the same receptor demonstrates a much lower affinity than would be predicted for the binding of zinterol to a /3 2 -receptor [20 nM (Minneman et al., 1979a, 1979b, and  
Distribution of 0-Receptor Subtypes in Nonmyocyte Membranes
Because we detected only ft-receptors on ventricular myocytes, we anticipated that membranes prepared from the nonmyocyte components of the ventricle would reveal the presence of fo-adrenergic receptors. Saturation isotherms produced under conditions identical to those used to assay [ 125 I]ICYP binding to purified myocytes gave linear Scatchard curves (Fig. 4) , indicating that the nonselective radiolabeled antagonist recognizes a single class of binding sites in nonmyocyte membranes (kinetic parameters summarized in Table 2 ). However, competition of [ these membranes was compared with and without 100 fiM added GTP, the guanine nucleotide caused only a small rightward shift in the high and low affinity components of binding. This slight shift caused no change in the estimation of proportions of ft-and ft-receptors present (Fig. 6) .
The resolution of ft-and ft-receptors by betaxolol, practolol, and zinterol, the appropriateness of their affinities, and the excellent agreement on the relative densities of the receptor subtypes determined by these agents, demonstrate convincingly that the nonmyocyte fraction contains ft-as well as ft-receptors.
Confirmation of the ability of methods applied here to detect ft-adrenergic receptors was provided by identical studies performed on a tissue known to be a homogeneous source of ft-adrenergic receptors (Minneman et al., 1979c) . Binding of p ]ICYP binding to liver membranes by subtype-specific antagonists gave monophasic curves with affinities for zinterol and practolol appropriate for a ft-receptor (15 and 760 nM, respectively).
Discussion
We have employed radioligand-binding techniques to investigate the distribution of ft-adrenergic receptors in rat myocardium, a tissue known to contain both ft-and ft-receptors (Minneman, 1979a, 1979b, and  Table 1 ). Our work differs from previous studies in two principal ways. First, we have purified ventricular myocytes from rat heart and are thus able to compare receptor binding data from whole ventricle, purified cardiomyocytes, myocyte membranes, and the nonmyocyte fraction of ventricle. Second, we provide data on ftadrenergic receptors present on fully differentiated, intact car- diomyocytes freshly prepared from adult animals, in contrast to an earlier study employing fetal myoblasts adapted to tissue culture (Lau et al., 1980) .
Employing antagonists selective for ft-or /^-receptors and the /3-specific radioligand [ 125 I]ICYP, we find a single class of ft -receptors on purified ventricular myocytes. In the nonmyocyte fraction, however, approximately 50% of ft-receptors are of the ft-subtype, data consistent with reports of as many as 24% /3 2 -receptors in rat heart ventricle ( Table 1, and Minneman et al., 1979a and Minneman et al., , 1979b , since our preparation represents a purification of both myocyte (all ft) and nonmyocyte elements (contributing /32-receptors). Indeed, it seems likely to us that many of the ft-receptors identified in the nonmyocyte fraction of ventricle are contributed by damaged myocytes that are excluded during myocyte purification. • It is, of course, possible that cardiomyocytes have a small fraction of j8 2 -receptors that we failed to detect. Applying the analysis described by DeLean et al. (1981) , we can estimate the limits of our ability to discern a small population of /3 2 -receptors. In using a subtype-specific antagonist with a nonspecific labeled ligand in a competitive binding assay, one needs an antagonist that exhibits a selectivity between ft-and ft-receptors of ~50 to detect as few as 10% ft-receptors. In our experiments, the selectivities of the compounds were ~20 for practolol and zinterol and ~60 for betaxolol. Thus, within these limits (10% /8 2 -receptors), which are the likely limits imposed by experimental error, we do not detect /3 2 -receptors on the adult cardiomyocyte.
The number of ft-receptors found on each adult myocyte, ~2 X 10 5 , seems, at first glance, large. This high density of receptor on the intact myocyte manifests itself as an appropriately high content of receptors in isolated membranes, ~162 fmol/mg pro- tein. Our estimate compares favorably with that of Moustafa et al. (1978) (Dibner et al., 1981) , and 20 receptors//um 2 for the BC3H-1 smooth muscle cell (calculated from data of Hughes et al. (1982) and Brown et al. (1984) . Thus, the prevalence of ftadrenergic receptors per unit area of myocyte membrane is not unusually high. Furthermore, if surface receptor density is a way in which cells regulate their adrenergic responsiveness (Shear et al., 1976) , then this number of ftreceptors in a highly responsive tissue such as heart seems reasonable.
The presence of ft-but not ft-receptors on rat myocytes implies that the metabolic and contractile response of rat ventricular muscle to ftagonists results exclusively from occupation of ft -receptors. This conclusion varies from that reached by Robberecht et al. (1983) and Waelbroeck et al. (1983) . These workers have recently offered evidence that human cardiac tissue has equal contents of ft-and ft-receptors, and that only the ft-adrenergic receptors are coupled to adenylate cyclase. These studies must be accepted with caution, however, since the tissues employed were largely atrial and were from patients who had been receiving ftblockade therapy. In addition, these human tissues, removed during surgical repair of coronary insufficiency or valvular disease, very likely represent diseased rather than normal tissue and were certainly a population of mixed cell types. The sort of study that we have performed emphasizes the utility of a purified cell population and provides a direct test of the proposal of Waelbroech and colleagues (1983) .
